In the wake of previous examples of bispecific anti-TNFα antibodies, it is conceivable that a bispecific anti-TNFα antibody, that allows receptor-mediated transcytosis, may be of particular interest for therapy studies in PD patients. The gene discussed is TNF; the disease is Parkinson disease.